Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 100651-100700 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04562558
Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia
NAActive, not recruiting
228 participants
Started: Sep 29, 2020 · Completed: Dec 31, 2025
7 conditions1 sponsor1 location
NCT04378400
An Institutional Audit of the Short Term Complications and Long Term Outcomes of Patients Undergoing Laparoscopic Sacrocolpopexy for Vault/cervical Prolapse.
N/AEnrolling by invitation
250 participants
Started: Sep 29, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04174703
Preparing for Eating Disorders Treatment Through Compassionate Letter-Writing
NAEnrolling by invitation
160 participants
Started: Sep 29, 2020 · Completed: Dec 31, 2026
5 conditions2 sponsors1 location
NCT04400695
A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2
PHASE3Recruiting
366 participants
Started: Sep 29, 2020 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT04210505
Nasal Decolonization of Dialysis Patients Noses
PHASE4Active, not recruiting
302 participants
Started: Sep 29, 2020 · Completed: Jan 31, 2024
1 condition7 sponsors5 locations
NCT04405700
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
N/ARecruiting
2,800 participants
Started: Sep 29, 2020 · Completed: May 31, 2026
4 conditions1 sponsor1 location
NCT04666727
Role of Diet on the Microbiome of the Digestive System
N/ARecruiting
30 participants
Started: Sep 29, 2020 · Completed: Jan 1, 2026
1 condition1 sponsor1 location
NCT04317664
Intervention to Improve Driving Practices Among High-Risk Teen Drivers
PHASE3Recruiting
480 participants
Started: Sep 28, 2020 · Completed: Dec 15, 2025
4 conditions4 sponsors1 location
NCT04422236
A Post-market, Observational Registry With the easyEndoTM Universal Linear Cutting Stapler in Laparoscopic Bariatric Surgery
N/AActive, not recruiting
200 participants
Started: Sep 28, 2020 · Completed: May 31, 2025
4 conditions1 sponsor1 location
NCT04533958
Evaluation of Hypnosis in Virtual Reality on the Anxiety of Patients With Metastatic Prostate Cancer Over Chemotherapy
NARecruiting
60 participants
Started: Sep 28, 2020 · Completed: Feb 28, 2027
1 condition1 sponsor6 locations
NCT07104513
Efficacy and Influencing Factors of Repeated Low-level Red-light in Myopia
N/AActive, not recruiting
3,000 participants
Started: Sep 28, 2020 · Completed: Jul 28, 2030
1 condition1 sponsor2 locations
NCT07186010
Immunogenomic Dynamics and Biomarkers in Patients With Hepatocellular Carcinoma Receiving Immunotherapy
N/ARecruiting
50 participants
Started: Sep 28, 2020 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT04579835
Twin A Breech External Cephalic Version Intervention Trial (TWEXIT)
N/ARecruiting
45 participants
Started: Sep 28, 2020 · Completed: Sep 28, 2026
2 conditions1 sponsor1 location
NCT06387498
Testicular Tissue Cryopreservation (TTC)
NARecruiting
60 participants
Started: Sep 28, 2020 · Completed: Dec 30, 2027
1 condition1 sponsor1 location
NCT04360265
Follow-up Study of AAV-Mediated Gene Transfer (UX111; Previously Known as ABO-102) for MPS Type IIIA
PHASE3Enrolling by invitation
41 participants
Started: Sep 28, 2020 · Completed: Aug 31, 2027
4 conditions1 sponsor4 locations
NCT04214834
Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)
PHASE3Active, not recruiting
189 participants
Started: Sep 28, 2020 · Completed: Jun 30, 2026
1 condition2 sponsors24 locations
NCT04285112
SPRINT: Signature for Pain Recovery IN Teens
N/AActive, not recruiting
275 participants
Started: Sep 28, 2020 · Completed: Dec 31, 2025
4 conditions5 sponsors4 locations
NCT04186832
Step Count Monitoring as a Measure of Physical Activity in Patients With Newly Diagnosed Glioma Undergoing Radiation Therapy
NAActive, not recruiting
50 participants
Started: Sep 28, 2020 · Completed: Dec 31, 2027
2 conditions2 sponsors1 location
NCT04444869
Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer
PHASE2Recruiting
28 participants
Started: Sep 28, 2020 · Completed: Jun 30, 2026
4 conditions1 sponsor1 location
NCT04450628
Esophagogastric Junction Distensibility During Hiatal Hernia Repair
NARecruiting
50 participants
Started: Sep 28, 2020 · Completed: Aug 31, 2026
2 conditions2 sponsors1 location
NCT04618653
Comprehensive Process Model of AA-related Behavior Change
N/AActive, not recruiting
192 participants
Started: Sep 28, 2020 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04606771
A Study Comparing Savolitinib Plus Osimertinib vs Savolitinib Plus Placebo in Patients With EGFRm+ and MET Amplified Advanced NSCLC
PHASE2Active, not recruiting
30 participants
Started: Sep 28, 2020 · Completed: Mar 30, 2026
1 condition1 sponsor21 locations
NCT04156061
Effect of the SCOT-HEART 2 Trial on Lifestyle.
NARecruiting
400 participants
Started: Sep 28, 2020 · Completed: Jul 7, 2027
2 conditions3 sponsors1 location
NCT04494672
A Study to Verify if the Surgery for the Proximal Femur Fracture Can be Improved With the Help of a Navigation System
NARecruiting
96 participants
Started: Sep 28, 2020 · Completed: Aug 1, 2025
1 condition1 sponsor1 location
NCT04564521
Nitroglycerin for Intra-arterial Chemotherapy in Pediatric Retinoblastoma.
NARecruiting
36 participants
Started: Sep 28, 2020 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT04543617
A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy
PHASE3Active, not recruiting
760 participants
Started: Sep 28, 2020 · Completed: Mar 31, 2027
1 condition1 sponsor165 locations
NCT04501120
Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML
PHASE1/PHASE2Recruiting
458 participants
Started: Sep 28, 2020 · Completed: Sep 30, 2029
2 conditions2 sponsors12 locations
NCT04639297
NeuroVision vs Standard Neuromonitoring
NARecruiting
148 participants
Started: Sep 28, 2020 · Completed: Jun 20, 2027
1 condition1 sponsor1 location
NCT04688411
An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease
NARecruiting
40 participants
Started: Sep 28, 2020 · Completed: Feb 1, 2025
4 conditions2 sponsors1 location
NCT04420754
Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer
PHASE1Active, not recruiting
70 participants
Started: Sep 28, 2020 · Completed: Aug 4, 2030
2 conditions1 sponsor4 locations
NCT04685226
A Phase I/II Clinical Trial of ICP-723 in the Treatment of Advanced Solid Tumors
PHASE1/PHASE2Recruiting
310 participants
Started: Sep 27, 2020 · Completed: Feb 25, 2028
1 condition1 sponsor24 locations
NCT04333706
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
PHASE1/PHASE2Recruiting
65 participants
Started: Sep 26, 2020 · Completed: Sep 1, 2027
5 conditions2 sponsors3 locations
NCT04528004
Mechanistic Studies of Nicotinamide Riboside in Human Heart Failure
EARLY_PHASE1Active, not recruiting
32 participants
Started: Sep 26, 2020 · Completed: Jul 31, 2025
3 conditions2 sponsors1 location
NCT04213014
Guys/Girls Opt for Activities for Life Trial (GOAL) to Increase Young Adolescents' Physical Activity and Healthy Eating
NAActive, not recruiting
935 participants
Started: Sep 26, 2020 · Completed: Aug 31, 2026
1 condition3 sponsors2 locations
NCT04738162
Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors
PHASE2Recruiting
80 participants
Started: Sep 25, 2020 · Completed: Jun 30, 2025
1 condition3 sponsors7 locations
NCT04375228
Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs)
PHASE2Active, not recruiting
8 participants
Started: Sep 25, 2020 · Completed: Feb 28, 2026
2 conditions2 sponsors3 locations
NCT04488822
A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT
PHASE3Active, not recruiting
40 participants
Started: Sep 25, 2020 · Completed: Feb 28, 2026
1 condition1 sponsor9 locations
NCT04555174
BIOFLOW-VIII All-comers Orsiro Mission Safety and Performance Registry
N/AActive, not recruiting
872 participants
Started: Sep 25, 2020 · Completed: Feb 19, 2027
2 conditions2 sponsors41 locations
NCT03682081
Interventions for Patients With Alzheimer's Disease and Dysphagia
NAActive, not recruiting
76 participants
Started: Sep 25, 2020 · Completed: Nov 30, 2025
3 conditions2 sponsors1 location
NCT04489173
TAS102 in Patients With ER-positive, HER2-negative Advanced Breast Cancer
PHASE2Active, not recruiting
52 participants
Started: Sep 25, 2020 · Completed: Nov 30, 2025
2 conditions5 sponsors10 locations
NCT04288427
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
NARecruiting
120 participants
Started: Sep 25, 2020 · Completed: Nov 30, 2025
8 conditions2 sponsors1 location
NCT04483739
Isa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation (IsKia TRIAL)
PHASE3Active, not recruiting
302 participants
Started: Sep 25, 2020 · Completed: Dec 31, 2032
1 condition4 sponsors41 locations
NCT04882904
Continuous Measurement of Activity in Patients with Muscle Pathology and in Control Subjects. ActiSLA Part.
NARecruiting
45 participants
Started: Sep 25, 2020 · Completed: May 31, 2025
1 condition3 sponsors1 location
NCT04676204
Relationship Between Oral DMT Burden and Adherence in MS
N/AEnrolling by invitation
323 participants
Started: Sep 25, 2020 · Completed: Jul 11, 2026
2 conditions1 sponsor1 location
NCT04571138
A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or Lymphoma
PHASE1/PHASE2Recruiting
42 participants
Started: Sep 25, 2020 · Completed: Feb 29, 2040
2 conditions1 sponsor5 locations
NCT04739826
Flumatinib Versus Nilotinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
N/ARecruiting
491 participants
Started: Sep 25, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04020809
Neoadjuvant Atezolizumab in Cutaneous Melanoma
PHASE1Active, not recruiting
20 participants
Started: Sep 25, 2020 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04522700
Reconstruction of Maxillary and Midfacial Defects Using Latissimus Dorsi Scapular Free Flaps
NANot yet recruiting
30 participants
Started: Sep 25, 2020 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT03641456
VRD as Induction Followed by VR Maintenance in Patients With Newly Diagnosed High Risk Multiple Myeloma
PHASE2Recruiting
50 participants
Started: Sep 25, 2020 · Completed: Dec 30, 2025
3 conditions1 sponsor1 location
NCT04228367
JuggerStitch Post Market Clinical Follow-up Study
NARecruiting
104 participants
Started: Sep 25, 2020 · Completed: Apr 30, 2026
2 conditions1 sponsor6 locations